Skip to main content
TipRanks
Go Ultimate75% OFF

Ruedi Stalder Insider Profile

4 Followers

Ruedi Stalder, Director at Eloxx Pharmaceuticals, holds 1.05M shares in Eloxx Pharmaceuticals (Ticker: ELOX).

Ruedi Stalder's Trading History

ELOX
Eloxx Pharmaceuticals
May 27, 2010DirectorUninformative Buy16.29K$13.86M
ELOX
Insider Shares: 1.05M (5.16%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
May 27, 2010Informative Buy$523.88K631,176$0.83-51.20%
May 27, 2010Uninformative Buy$16.29K40,213$0.40―
Feb 23, 2010Uninformative Buy$0.00135,779$0.00―
Jul 31, 2009Uninformative Buy$0.0027,188$0.00―
Jul 31, 2009Informative Buy$13.50K15,000$0.90-52.90%

You May Also Like

Ruedi Stalder insider profile FAQ

What is the percentage of profitable transactions made by Ruedi Stalder?
The percentage of profitable transactions made by Ruedi Stalder is 0%.
What is the average return per transaction made by Ruedi Stalder?
The average return per transaction made by Ruedi Stalder is -33.90%.
What stocks does Ruedi Stalder hold?
Ruedi Stalder holds: ELOX stocks.
What was Ruedi Stalder’s latest transaction?
Ruedi Stalder’s latest transaction was an Uninformative Buy of $16.29K.
What was Ruedi Stalder's most profitable transaction?
Ruedi Stalder’s most profitable transaction was an Informative Buy of ELOX stock on March 12, 2009. The return on the trade was -2.40%.
What is Ruedi Stalder's role in Eloxx Pharmaceuticals?
Ruedi Stalder's role in Eloxx Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.